ZIM Laboratories Limited (NSE:ZIMLAB)

Market Cap	3.91B
Revenue (ttm)	3.88B
Net Income (ttm)	153.66M
Shares Out	n/a
EPS (ttm)	3.15
PE Ratio	25.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	164,672
Average Volume	356,174
Open	82.20
Previous Close	81.89
Day's Range	80.00 - 85.29
52-Week Range	79.49 - 131.40
Beta	0.53
RSI	35.28
Earnings Date	May 13, 2025

About ZIM Laboratories

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. It offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1984
• Employees: 556
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ZIMLAB

Financial Performance

In 2023, ZIM Laboratories's revenue was 3.68 billion, a decrease of -7.80% compared to the previous year's 3.99 billion. Earnings were 172.46 million, a decrease of -29.42%.